Literature DB >> 3857012

Tourette syndrome, pimozide, and school phobia: the neuroleptic separation anxiety syndrome.

L S Linet.   

Abstract

The development of school phobia has been reported in some patients with Tourette syndrome treated with haloperidol. The author reports on a patient who developed school phobia on each of three trials with pimozide, a neuroleptic chemically similar to haloperidol, and proposes the term "neuroleptic separation anxiety syndrome." The syndrome is clinically indistinguishable from DSM-III criteria for school phobia (separation anxiety disorder). Tricyclic antidepressants may have a therapeutic or prophylactic effect. It is not known whether this neuroleptic side effect occurs in patients other than those with Tourette syndrome.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3857012     DOI: 10.1176/ajp.142.5.613

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  7 in total

Review 1.  Separation anxiety disorder in children and adolescents: epidemiology, diagnosis and management.

Authors:  G Masi; M Mucci; S Millepiedi
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  Neuroleptic-induced emotional defecation: effects of scopolamine and haloperidol.

Authors:  P R Sanberg; K H Russell; S H Hagenmeyer-Houser; M Giordano; E M Zubrycki; D L Garver
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  A controlled study of Tourette syndrome. III. Phobias and panic attacks.

Authors:  D E Comings; B G Comings
Journal:  Am J Hum Genet       Date:  1987-11       Impact factor: 11.025

4.  Haloperidol-induced emotional defecation: a possible model for neuroleptic anxiety syndrome.

Authors:  K H Russell; S H Hagenmeyer-Houser; P R Sanberg
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 5.  Neuroleptic dysphoria: towards a new synthesis.

Authors:  L Voruganti; A G Awad
Journal:  Psychopharmacology (Berl)       Date:  2003-11-27       Impact factor: 4.530

6.  European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.

Authors:  Veit Roessner; Kerstin J Plessen; Aribert Rothenberger; Andrea G Ludolph; Renata Rizzo; Liselotte Skov; Gerd Strand; Jeremy S Stern; Cristiano Termine; Pieter J Hoekstra
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-04       Impact factor: 4.785

7.  Social phobia following maprotiline: the first case report.

Authors:  Seyed Hamzeh Hosseini; Ebrahim Salehifar
Journal:  Cases J       Date:  2009-12-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.